EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Photoimmuno‐Lure Nanoplatform for Enhancing T Cell Expansion in Glioblastoma via Synergistic Treatment of Photodynamic Therapy and Immune Checkpoint Inhibition

Minji Ahn iD, Yuhyun Na, Hani Choi, Sanghee Lee, Jangsu Lee, Soon A Park, Sin-Soo Jeun, Kun Na iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202500880 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Minji Ahn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea. Hauptthemen laut MEDLINE: Glioblastoma, Photochemotherapy, Immune Checkpoint Inhibitors, Photosensitizing Agents. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Technology development Program, Ministry of SMEs and Startups, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immunosuppressive tumor microenvironment (TME) of glioblastoma (GBM) limits the efficacy of immune checkpoint inhibitors (ICI), primarily due to the absence of cytotoxic T (T c ) cells. In this study, a photoimmuno‐lure nanoplatform is presented that combines amphiphilic photosensitizers (PSs) with Atezolizumab leading to the modulation of the TME of GBM and improvement of the therapeutic efficacy through synergistic photodynamic therapy (PDT). The amphiphilic PSs exhibited four‐fold higher GBM specificity, superior photostability, and enhanced singlet oxygen generation efficiency ( 1 O 2 Φ Δ : 0.92) compared to conventional PSs. In in vitro GBM cell lines, amphiphilic PSs increased immune activation cytokines and improved ICI responsiveness compared to single ICI treatment. In addition, similar results are acquired in a GBM 3D spheroid model, showing significantly elevated T c cell activation. In orthotopic in vivo GBM model, the nanoplatform achieved a 100% survival rate for up to 60 days. Immunological analysis revealed each 2.36‐fold, 4.19‐fold increase in activated dendritic cells and T c cells respectively, and significant reductions in MDSCs (0.48‐fold) and regulatory T cells (0.5‐fold). As a result, this study demonstrates the potential of the synergistic photoimmuno‐lure nanoplatform as a clinical solution to overcome the immunosuppressive TME of GBM and activate innate and adaptive immunity for effective treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaPhotochemotherapyImmune Checkpoint InhibitorsPhotosensitizing AgentsBrain NeoplasmsAnimalsHumansMiceCell Line, TumorTumor MicroenvironmentAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

glioblastoma multiformeimmune checkpoint inhibitorimmunotherapyphotodynamic therapyphotosensitizer

Substanzen

Immune Checkpoint InhibitorsPhotosensitizing AgentsatezolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Biotechnology, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
  • Department of Radiology, Feinburg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
  • NBR incorporation, BI 205, 43 Jibong-ro, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
  • Department of Biomedical-Chemical Engineering, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
  • Department of Biomedical Science, Institute of Cell and Gene Therapy, CHA University, CHA Biocomplex, 335 Pangyo-ro, Sampyeong-Dong, Bundang-gu, Seongnam-si, Gyeonggi-Do, 13488, Republic of Korea.
  • Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.

ORCID-Profile: Minji Ahn, Kun Na

Förderung

  • Technology development Program
  • Ministry of SMEs and Startups
  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Ahn, M., Na, Y., Choi, H., Lee, S., Lee, J., Park, S. A., Jeun, S. S., & Na, K. (2025). Photoimmuno‐Lure Nanoplatform for Enhancing T Cell Expansion in Glioblastoma via Synergistic Treatment of Photodynamic Therapy and Immune Checkpoint Inhibition. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500880

Vancouver

Ahn M, Na Y, Choi H, Lee S, Lee J, Park SA, et al. Photoimmuno‐Lure Nanoplatform for Enhancing T Cell Expansion in Glioblastoma via Synergistic Treatment of Photodynamic Therapy and Immune Checkpoint Inhibition. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500880

BibTeX
@article{Ahn2025,
  author = {Ahn, Minji and Na, Yuhyun and Choi, Hani and Lee, Sanghee and Lee, Jangsu and Park, Soon A and Jeun, Sin-Soo and Na, Kun},
  title = {Photoimmuno‐Lure Nanoplatform for Enhancing T Cell Expansion in Glioblastoma via Synergistic Treatment of Photodynamic Therapy and Immune Checkpoint Inhibition},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202500880}
}
Kostenlos starten →